{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-025588","form_type":"8-K","ticker":"LNTH","cik":"0001521036","company_name":"Lantheus Holdings, Inc.","filed_at":"2023-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.372764+00:00","generated_at":"2026-06-20T00:01:39.339091+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"medium","headline":"Lantheus acquires Cerveau Technologies, adding Alzheimer's Tau PET imaging agent MK-6240","bullets":["Acquired Cerveau Technologies, gaining MK-6240, an F18-labeled PET imaging agent targeting Tau tangles in Alzheimer's disease.","MK-6240 is currently used in over 60 academic and industry clinical trials by more than 16 pharmaceutical companies.","Terms include upfront payment plus development and commercial milestone payments, with double-digit royalties on research revenue and commercial sales.","Transaction structured as a stock purchase; seller to provide transition and clinical development services post-closing.","Lantheus expects to expand its radiopharmaceutical diagnostic imaging pipeline into Alzheimer's disease."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-025588","json":"https://secwatch.observer/filing/0001193125-23-025588.json","markdown":"https://secwatch.observer/filing/0001193125-23-025588.md","text":"https://secwatch.observer/filing/0001193125-23-025588.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1521036/000119312523025588/0001193125-23-025588-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1521036/000119312523025588/d462129d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T00:01:39.339091+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}